Salvianolic Acid B Alleviates Liver Injury by Regulating Lactate-Mediated Histone Lactylation in Macrophages
Salvianolic acid B (Sal B) is the primary water-soluble bioactive constituent derived from the roots of <i<Salvia miltiorrhiza</i< Bunge. This research was designed to reveal the potential mechanism of Sal B anti-liver injury from the perspective of macrophages. In our lipopolysaccharide-induced M1 macrophage model, Sal B showed a clear dose-dependent gradient of inhibition of the macrophage trend of the M1 type. Moreover, Sal B downregulated the expression of lactate dehydrogenase A (LDHA), while the overexpression of LDHA impaired Sal B’s effect of inhibiting the trend of macrophage M1 polarization. Additionally, this study revealed that Sal B exhibited inhibitory effects on the lactylation process of histone H3 lysine 18 (H3K18la). In a ChIP-qPCR analysis, Sal B was observed to drive a reduction in H3K18la levels in the promoter region of the LDHA, NLRP3, and IL-1β genes. Furthermore, our in vivo experiments showed that Sal B has a good effect on alleviating CCl<sub<4</sub<-induced liver injury. An examination of liver tissues and the Kupffer cells isolated from those tissues proved that Sal B affects the M1 polarization of macrophages and the level of histone lactylation. Together, our data reveal that Sal B has a potential mechanism of inhibiting the histone lactylation of macrophages by downregulating the level of LDHA in the treatment of liver injury..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Molecules - 29(2024), 1, p 236 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shian Hu [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
H3K18la |
---|
doi: |
10.3390/molecules29010236 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ09778091X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ09778091X | ||
003 | DE-627 | ||
005 | 20240413194244.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/molecules29010236 |2 doi | |
035 | |a (DE-627)DOAJ09778091X | ||
035 | |a (DE-599)DOAJa38783f4a8764f21ab3f4c3abadfd1f1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QD241-441 | |
100 | 0 | |a Shian Hu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Salvianolic Acid B Alleviates Liver Injury by Regulating Lactate-Mediated Histone Lactylation in Macrophages |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Salvianolic acid B (Sal B) is the primary water-soluble bioactive constituent derived from the roots of <i<Salvia miltiorrhiza</i< Bunge. This research was designed to reveal the potential mechanism of Sal B anti-liver injury from the perspective of macrophages. In our lipopolysaccharide-induced M1 macrophage model, Sal B showed a clear dose-dependent gradient of inhibition of the macrophage trend of the M1 type. Moreover, Sal B downregulated the expression of lactate dehydrogenase A (LDHA), while the overexpression of LDHA impaired Sal B’s effect of inhibiting the trend of macrophage M1 polarization. Additionally, this study revealed that Sal B exhibited inhibitory effects on the lactylation process of histone H3 lysine 18 (H3K18la). In a ChIP-qPCR analysis, Sal B was observed to drive a reduction in H3K18la levels in the promoter region of the LDHA, NLRP3, and IL-1β genes. Furthermore, our in vivo experiments showed that Sal B has a good effect on alleviating CCl<sub<4</sub<-induced liver injury. An examination of liver tissues and the Kupffer cells isolated from those tissues proved that Sal B affects the M1 polarization of macrophages and the level of histone lactylation. Together, our data reveal that Sal B has a potential mechanism of inhibiting the histone lactylation of macrophages by downregulating the level of LDHA in the treatment of liver injury. | ||
650 | 4 | |a macrophages | |
650 | 4 | |a salvianolic acid B | |
650 | 4 | |a LDHA | |
650 | 4 | |a histone lactylation | |
650 | 4 | |a H3K18la | |
650 | 4 | |a liver injury | |
653 | 0 | |a Organic chemistry | |
700 | 0 | |a Zehua Yang |e verfasserin |4 aut | |
700 | 0 | |a Ling Li |e verfasserin |4 aut | |
700 | 0 | |a Qinwen Yan |e verfasserin |4 aut | |
700 | 0 | |a Yutong Hu |e verfasserin |4 aut | |
700 | 0 | |a Feng Zhou |e verfasserin |4 aut | |
700 | 0 | |a Yang Tan |e verfasserin |4 aut | |
700 | 0 | |a Gang Pei |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Molecules |d MDPI AG, 2003 |g 29(2024), 1, p 236 |w (DE-627)DOAJ000105902 |x 14203049 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2024 |g number:1, p 236 |
856 | 4 | 0 | |u https://doi.org/10.3390/molecules29010236 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/a38783f4a8764f21ab3f4c3abadfd1f1 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/1420-3049/29/1/236 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1420-3049 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 29 |j 2024 |e 1, p 236 |